[Buserelin--a GnRh analog for the treatment of endometriosis]. / Buserelin--ein GnRh-Analogon zur Behandlung der Endometriose.
Schweiz Rundsch Med Prax
; 78(14): 399-402, 1989 Apr 04.
Article
in De
| MEDLINE
| ID: mdl-2524870
Within the scope of an open study, the results after treatment with Buserelin for patients with endometriosis is appraised. The patients are studied by laparoscopy or laparotomy before and after a six-month-long treatment. A clear decline of the endometriosis can be seen; however, endometriomas showed little or no reaction. The Buserelin therapy is shown to be well tolerated. It increases the rate of pregnancies, gives few biochemical complications and is an entirely acceptable therapy with few side effects. Buserelin offers a real alternative for the pharmacotherapy of endometriosis.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Buserelin
/
Endometriosis
Limits:
Adult
/
Female
/
Humans
Language:
De
Journal:
Schweiz Rundsch Med Prax
Year:
1989
Document type:
Article
Country of publication:
Switzerland